These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26104179)

  • 1. Impact of Admission Anemia on Coronary Microcirculation and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Uchida Y; Ichimiya S; Ishii H; Kanashiro M; Watanabe J; Hayano S; Suzuki S; Takeshita K; Sakai S; Amano T; Matsubara T; Murohara T
    Int Heart J; 2015; 56(4):381-8. PubMed ID: 26104179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction.
    Fukunaga M; Fujii K; Kawasaki D; Sawada H; Miki K; Tamaru H; Imanaka T; Iwasaku T; Nakata T; Shibuya M; Akahori H; Masutani M; Kobayashi K; Ohyanagi M; Masuyama T
    Circ Cardiovasc Interv; 2014 Apr; 7(2):149-55. PubMed ID: 24550440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.
    Haeck JD; Koch KT; Bilodeau L; Van der Schaaf RJ; Henriques JP; Vis MM; Baan J; Van der Wal AC; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    JACC Cardiovasc Interv; 2009 Oct; 2(10):934-43. PubMed ID: 19850252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metabolic syndrome on various aspects of microcirculation and major adverse cardiac events in patients with ST-segment elevation myocardial infarction.
    Uchida Y; Ichimiya S; Ishii H; Kanashiro M; Watanabe J; Yoshikawa D; Takeshita K; Sakai S; Amano T; Matsubara T; Murohara T
    Circ J; 2012; 76(8):1972-9. PubMed ID: 22664935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Emre A; Terzi S; Celiker E; Sahin S; Yazıcı S; Erdem A; Ceylan US; Asik M; Yesilcimen K
    Am J Cardiol; 2015 Dec; 116(12):1810-4. PubMed ID: 26506122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
    Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I
    Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Demidova MM; Carlson J; Erlinge D; Platonov PG
    Am J Cardiol; 2015 Feb; 115(4):417-22. PubMed ID: 25549882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.
    Greenberg G; Assali A; Vaknin-Assa H; Brosh D; Teplitsky I; Fuchs S; Battler A; Kornowski R; Lev EI
    Am J Cardiol; 2010 Feb; 105(4):435-40. PubMed ID: 20152235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
    Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Porto I; De Maria GL; Leone AM; Dato I; D'Amario D; Burzotta F; Niccoli G; Trani C; Biasucci LM; Bolognese L; Crea F
    Am J Cardiol; 2013 Sep; 112(6):782-91. PubMed ID: 23746481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study.
    Wong DT; Leung MC; Das R; Puri R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):746-53. PubMed ID: 22422674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Taniguchi T; Shiomi H; Toyota T; Morimoto T; Akao M; Nakatsuma K; Ono K; Makiyama T; Shizuta S; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Horie M; Kimura T
    Am J Cardiol; 2014 Oct; 114(8):1179-86. PubMed ID: 25159235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.